Fecal alpha-1-antitrypsin excretion in children with diarrhea

B Lisowska-Myjak1, J Pachecka, O Sokrates

  • 1Dept. of Biochemistry and Clinical Chemistry, Medical University of Warsaw, Poland.

Insights

Fecal alpha-1-antitrypsin (AAT) levels are elevated in chronic infectious and non-infectious diarrhea but not acute diarrhea in children. Fecal AAT determination may help differentiate diarrhea types.

Area of Science:

  • Gastroenterology
  • Biochemistry

Background:

  • Alpha-1-antitrypsin (AAT) is a protein with anti-inflammatory properties.
  • Fecal AAT levels can indicate gastrointestinal inflammation and protein loss.

Purpose of the Study:

  • To compare fecal AAT concentration and characterization in children with acute and chronic diarrhea versus healthy controls.
  • To assess the clinical utility of fecal AAT in differentiating diarrhea types.

Main Methods:

  • Radial immunodiffusion and crossed immunoelectrophoresis were used to analyze fecal AAT.
  • Study included 32 children with diarrhea and 23 healthy children.

Main Results:

  • Elevated fecal AAT concentrations were observed in chronic infectious and non-infectious diarrhea, but not acute diarrhea.
  • Immunoelectrophoresis revealed two fecal AAT forms in all children, with no correlation to concentration changes.

Conclusions:

  • Fecal AAT measurement can provide valuable clinical information for distinguishing between infectious and non-infectious diarrhea.
  • Fecal AAT analysis may aid in characterizing the activity of diarrheal diseases.
Abstract

Related Concept Videos

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Drug Excretion: Miscellaneous Routes01:10

Drug Excretion: Miscellaneous Routes

Drug excretion involves various organs, including the liver, intestines, skin, and eyes. In the case of drugs or toxins, they can be actively secreted into bile by transporters in the hepatocyte's canalicular membrane. These substances enter the GI tract during digestion and may be reabsorbed into the body from the intestine. This process, known as enterohepatic recycling, can significantly prolong the presence and effects of a substance in the body. To interrupt this cycle, specific substances...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.